Zapatero-Belinchón, Francisco J. http://orcid.org/0000-0002-2751-8411
Kumar, Priti
Ott, Melanie http://orcid.org/0000-0002-5697-1274
Schwartz, Olivier http://orcid.org/0000-0002-0729-1475
Sigal, Alex
Article History
First Online: 28 August 2024
Competing interests
: A.S. has received an honorarium for consulting from Pfizer. M.O. is a founder of DirectBio and a board member of Invisishield Technologies. The other authors declare no competing interests.